Stiefel, the world's leading independent dermatology laboratory, is part of the Blackstone private equity group. A 160-year-old company, it produces a variety of skin care products, over and over again, including anti-itch creams and acne treatments.
Renowned for their research, their innovations and their expertise in the field of skin health, Stiefel Laboratories offer a complete range of products of very high quality and performance. In close collaboration with patients and experts in dermatology, Stiefel products are developed with the aim of providing an innovative response and to best meet the requirements of each type of skin. A subsidiary of the GSK group, Stiefel benefits from strong research and development sources, allowing it to always stay one step ahead in dermatological innovation.
Stiefel has a long history of excellence in dermatology and R&D focused on acne, psoriasis, eczema, atopic dermatitis and superficial skin infections.
Their product line spans from prescription to daily skin care, so we can deliver quality, science-based products that help meet individual treatment needs and improve overall quality of life for patients. people with skin problems.
Stiefel has market knowledge and business expertise in the pharmaceutical and consumer healthcare fields and our products are available in more than 130 countries. Through GSK's Emerging Markets Group, Stiefel is also increasing access to essential skin care products in regions such as Central Africa, at sustainable prices.
Stiefel is committed to developing scientific and differentiated products and innovations in areas where it has deep expertise, so that more people discover and benefit from healthy skin.
Our dedicated, specialist research team studies many fundamental aspects of skin science in our Skin Biology Center, including skin function, disease pathways, skin protection, repair and regeneration. . We are constantly working to learn more about disrupting normal and healthy patterns so that we can find potential new solutions for common and rare skin conditions. Stiefel has full development capabilities in topical, oral and injectable formulation for dermatology.
Stiefel also leverages GSK's extensive R&D capabilities, collaborating with teams studying relevant disease pathways in a variety of therapeutic areas, including immunoinflammation, infectious disease, oncology and healthcare. General public.
